Causes of Hypophosphatemia
Hypophosphatemia is caused by three primary mechanisms: inadequate intake or intestinal absorption, redistribution from extracellular to intracellular compartments, and excessive renal phosphate wasting. 1
Mechanisms of Hypophosphatemia
1. Inadequate Intake or Intestinal Absorption
- Malnutrition and starvation 2
- Malabsorptive disorders including:
- Inflammatory bowel disease
- Celiac disease
- Post-bariatric surgery 2
- Vitamin D deficiency leading to decreased intestinal phosphate absorption 1
- Chronic use of phosphate binders (aluminum, calcium, or magnesium-containing antacids) 2
2. Redistribution from Extracellular to Intracellular Compartments
- Refeeding syndrome - carbohydrate reintroduction after caloric deprivation causes insulin release, driving phosphate into cells 1
- Diabetic ketoacidosis treatment - insulin administration causes cellular uptake of phosphate 3
- Respiratory alkalosis - hyperventilation shifts phosphate intracellularly 4
- Recovery phase of metabolic acidosis 5
- Hungry bone syndrome after parathyroidectomy 4
3. Excessive Renal Phosphate Wasting
FGF23-Mediated Causes:
- Genetic disorders:
- Tumor-induced osteomalacia - tumors producing excess FGF23 1
- Iron therapy with intravenous ferric carboxymaltose - causes "6H-syndrome" (high FGF23, hyperphosphaturia, hypophosphataemia, hypovitaminosis D, hypocalcaemia, secondary hyperparathyroidism) 1, 2
- Advanced malignancies (especially prostate and lung cancer) causing ectopic FGF23 syndrome 1
- Alcohol-induced FGF23 syndrome 1
Non-FGF23 Mediated Causes:
- Primary hyperparathyroidism - elevated PTH increases phosphate excretion 4
- Secondary hyperparathyroidism due to vitamin D deficiency 4
- Renal tubular disorders:
- Kidney replacement therapy (KRT) - especially continuous or prolonged intermittent KRT modalities 1
- Prevalence of hypophosphatemia can rise to 80% during prolonged KRT 1
Clinical Severity Classification
Hypophosphatemia is classified by severity 2, 3:
- Mild: 2.0-2.5 mg/dL (0.65-0.81 mmol/L)
- Moderate: 1.0-2.0 mg/dL (0.32-0.65 mmol/L)
- Severe: <1.0 mg/dL (<0.32 mmol/L)
Diagnostic Approach
When evaluating hypophosphatemia, the following approach is recommended:
Measure fractional excretion of phosphate (FEP) 4
- FEP >15% with hypophosphatemia confirms renal phosphate wasting
- FEP <5% suggests non-renal causes
Assess FGF23 levels 1
- Elevated or inappropriately normal FGF23 with hypophosphatemia suggests FGF23-mediated disorders
- Low FGF23 suggests primary renal tubular defects
Check for metabolic acidosis, hypercalciuria, and other markers of renal tubular dysfunction to rule out Fanconi syndrome 1
Consider genetic testing for suspected hereditary disorders, particularly PHEX gene analysis for XLH 1, 2
Clinical Implications
Severe hypophosphatemia can lead to significant complications 4, 3:
- Respiratory muscle weakness and respiratory failure
- Cardiac dysfunction and arrhythmias
- Rhabdomyolysis
- Hemolytic anemia
- Neurological manifestations (confusion, seizures, coma)
- Impaired immune function
- Metabolic encephalopathy
In hospitalized patients, hypophosphatemia is associated with:
- Prolonged mechanical ventilation 1
- Increased risk of cardiac arrhythmias 1
- Extended hospital stays 1
- Overall negative impact on patient outcomes 1
Prevention in High-Risk Settings
For patients undergoing kidney replacement therapy:
- Use dialysis solutions containing phosphate to prevent hypophosphatemia 1
- Monitor electrolytes closely during intensive or prolonged KRT 1
For patients at risk of refeeding syndrome:
- Introduce nutrition gradually with appropriate phosphate supplementation 1
- Monitor phosphate levels frequently during refeeding 2
Understanding these diverse causes of hypophosphatemia is essential for proper diagnosis and management, ultimately improving patient outcomes by preventing the serious complications associated with severe phosphate depletion.